First Time Loading...
I

InBody Co Ltd
KOSDAQ:041830

Watchlist Manager
InBody Co Ltd
KOSDAQ:041830
Watchlist
Price: 26 700 KRW -0.56%
Updated: May 22, 2024

Intrinsic Value

InBody Co., Ltd. engages in the manufacture and sale of medical equipment. [ Read More ]

The intrinsic value of one InBody Co Ltd stock under the Base Case scenario is 34 248.8 KRW. Compared to the current market price of 26 700 KRW, InBody Co Ltd is Undervalued by 22%.

Key Points:
Intrinsic Value
Base Case
34 248.8 KRW
Undervaluation 22%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation Backtest
InBody Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling InBody Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
InBody Co Ltd

Provide an overview of the primary business activities
of InBody Co Ltd.

What unique competitive advantages
does InBody Co Ltd hold over its rivals?

What risks and challenges
does InBody Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for InBody Co Ltd.

Provide P/S
for InBody Co Ltd.

Provide P/E
for InBody Co Ltd.

Provide P/OCF
for InBody Co Ltd.

Provide P/FCFE
for InBody Co Ltd.

Provide P/B
for InBody Co Ltd.

Provide EV/S
for InBody Co Ltd.

Provide EV/GP
for InBody Co Ltd.

Provide EV/EBITDA
for InBody Co Ltd.

Provide EV/EBIT
for InBody Co Ltd.

Provide EV/OCF
for InBody Co Ltd.

Provide EV/FCFF
for InBody Co Ltd.

Provide EV/IC
for InBody Co Ltd.

Show me price targets
for InBody Co Ltd made by professional analysts.

What are the Revenue projections
for InBody Co Ltd?

How accurate were the past Revenue estimates
for InBody Co Ltd?

What are the Net Income projections
for InBody Co Ltd?

How accurate were the past Net Income estimates
for InBody Co Ltd?

What are the EPS projections
for InBody Co Ltd?

How accurate were the past EPS estimates
for InBody Co Ltd?

What are the EBIT projections
for InBody Co Ltd?

How accurate were the past EBIT estimates
for InBody Co Ltd?

Compare the revenue forecasts
for InBody Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of InBody Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of InBody Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of InBody Co Ltd compared to its peers.

Compare the P/E ratios
of InBody Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing InBody Co Ltd with its peers.

Analyze the financial leverage
of InBody Co Ltd compared to its main competitors.

Show all profitability ratios
for InBody Co Ltd.

Provide ROE
for InBody Co Ltd.

Provide ROA
for InBody Co Ltd.

Provide ROIC
for InBody Co Ltd.

Provide ROCE
for InBody Co Ltd.

Provide Gross Margin
for InBody Co Ltd.

Provide Operating Margin
for InBody Co Ltd.

Provide Net Margin
for InBody Co Ltd.

Provide FCF Margin
for InBody Co Ltd.

Show all solvency ratios
for InBody Co Ltd.

Provide D/E Ratio
for InBody Co Ltd.

Provide D/A Ratio
for InBody Co Ltd.

Provide Interest Coverage Ratio
for InBody Co Ltd.

Provide Altman Z-Score Ratio
for InBody Co Ltd.

Provide Quick Ratio
for InBody Co Ltd.

Provide Current Ratio
for InBody Co Ltd.

Provide Cash Ratio
for InBody Co Ltd.

What is the historical Revenue growth
over the last 5 years for InBody Co Ltd?

What is the historical Net Income growth
over the last 5 years for InBody Co Ltd?

What is the current Free Cash Flow
of InBody Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for InBody Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
InBody Co Ltd

Current Assets 149B
Cash & Short-Term Investments 98.9B
Receivables 17.5B
Other Current Assets 32.6B
Non-Current Assets 125.5B
Long-Term Investments 30.1B
PP&E 85.9B
Intangibles 1.2B
Other Non-Current Assets 8.2B
Current Liabilities 17.5B
Accounts Payable 155.8m
Accrued Liabilities 3B
Other Current Liabilities 14.3B
Non-Current Liabilities 8.2B
Long-Term Debt 3.6B
Other Non-Current Liabilities 4.6B
Efficiency

Earnings Waterfall
InBody Co Ltd

Revenue
170.4B KRW
Cost of Revenue
-37.9B KRW
Gross Profit
132.5B KRW
Operating Expenses
-94.1B KRW
Operating Income
38.3B KRW
Other Expenses
-1.6B KRW
Net Income
36.7B KRW

Free Cash Flow Analysis
InBody Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

InBody Co Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
Positive Operating Income
65/100
Profitability
Score

InBody Co Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

InBody Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

InBody Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
InBody Co Ltd

Wall Street analysts forecast InBody Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InBody Co Ltd is 37 740 KRW with a low forecast of 37 370 KRW and a high forecast of 38 850 KRW.

Lowest
Price Target
37 370 KRW
40% Upside
Average
Price Target
37 740 KRW
41% Upside
Highest
Price Target
38 850 KRW
46% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
InBody Co Ltd

Shareholder Return

Price
InBody Co Ltd

1M 1M
-5%
6M 6M
+11%
1Y 1Y
-1%
3Y 3Y
0%
5Y 5Y
+16%
10Y 10Y
+110%
Annual Price Range
26 700
52w Low
21 500
52w High
30 950
Price Metrics
Average Annual Return -0.61%
Standard Deviation of Annual Returns 26.39%
Max Drawdown -51%
Shares Statistics
Market Capitalization 347.8B KRW
Shares Outstanding 13 026 847
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

InBody Co Ltd

Country

Korea

Industry

Health Care

Market Cap

347.8B KRW

Dividend Yield

0.78%

Description

InBody Co., Ltd. engages in the manufacture and sale of medical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-12-14. The firm mainly produces body composition analyzers under the brand names of InBody and Lookin’Body. The firm mainly produces body composition analyzers under the brand name InBody and Lookin’Body. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include Lookin’Body3.0 and Lookin’Body Basic, which are used for measuring proteins, minerals, fats, moistures and others. The company also provides body mass index (BMI) measuring devices under the brand name of BSM. The firm distributes its products within domestic market and to overseas markets.

Contact

SEOUL
Seoul
InBody Bldg., 625, Eonju-ro, Gangnam-gu
+8225013939
http://www.inbody.co.kr/

IPO

2000-12-14

Employees

-

Officers

Chief Exec. Officer
Dr. Ki-Chul Cha
Managing Director
Yoon-Sun Shin
Exec. Officer
Ju-Sik Shin

See Also

Discover More
What is the Intrinsic Value of one InBody Co Ltd stock?

The intrinsic value of one InBody Co Ltd stock under the Base Case scenario is 34 248.8 KRW.

Is InBody Co Ltd stock undervalued or overvalued?

Compared to the current market price of 26 700 KRW, InBody Co Ltd is Undervalued by 22%.